These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 9886808
1. AP-1 and vitamin D receptor (VDR) signaling pathways converge at the rat osteocalcin VDR element: requirement for the internal activating protein-1 site for vitamin D-mediated trans-activation. Aslam F, McCabe L, Frenkel B, van Wijnen AJ, Stein GS, Lian JB, Stein JL. Endocrinology; 1999 Jan; 140(1):63-70. PubMed ID: 9886808 [Abstract] [Full Text] [Related]
2. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Staal A, Van Wijnen AJ, Desai RK, Pols HA, Birkenhäger JC, Deluca HF, Denhardt DT, Stein JL, Van Leeuwen JP, Stein GS, Lian JB. Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541 [Abstract] [Full Text] [Related]
3. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Staal A, van Wijnen AJ, Birkenhäger JC, Pols HA, Prahl J, DeLuca H, Gaub MP, Lian JB, Stein GS, van Leeuwen JP, Stein JL. Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469 [Abstract] [Full Text] [Related]
4. Control of 1,25-dihydroxyvitamin D3 receptor-mediated enhancement of osteocalcin gene transcription: effects of perturbing phosphorylation pathways by okadaic acid and staurosporine. Desai RK, van Wijnen AJ, Stein JL, Stein GS, Lian JB. Endocrinology; 1995 Dec; 136(12):5685-93. PubMed ID: 7588324 [Abstract] [Full Text] [Related]
5. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M, Freedman LP, Li H, Christakos S. Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705 [Abstract] [Full Text] [Related]
6. Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors. Liu M, Freedman LP. Mol Endocrinol; 1994 Dec; 8(12):1593-604. PubMed ID: 7708050 [Abstract] [Full Text] [Related]
7. YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene. Guo B, Aslam F, van Wijnen AJ, Roberts SG, Frenkel B, Green MR, DeLuca H, Lian JB, Stein GS, Stein JL. Proc Natl Acad Sci U S A; 1997 Jan 07; 94(1):121-6. PubMed ID: 8990171 [Abstract] [Full Text] [Related]
8. Variations in vitamin D receptor transcription factor complexes associated with the osteocalcin gene vitamin D responsive element in osteoblasts and osteosarcoma cells. Shakoori AR, van Wijnen AJ, Bortell R, Owen TA, Stein JL, Lian JB, Stein GS. J Cell Biochem; 1994 Jun 07; 55(2):218-29. PubMed ID: 8089197 [Abstract] [Full Text] [Related]
10. Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid x receptor. Mackey SL, Heymont JL, Kronenberg HM, Demay MB. Mol Endocrinol; 1996 Mar 07; 10(3):298-305. PubMed ID: 8833658 [Abstract] [Full Text] [Related]
11. Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Paredes R, Arriagada G, Cruzat F, Villagra A, Olate J, Zaidi K, van Wijnen A, Lian JB, Stein GS, Stein JL, Montecino M. Mol Cell Biol; 2004 Oct 07; 24(20):8847-61. PubMed ID: 15456860 [Abstract] [Full Text] [Related]
15. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1). Castillo AI, Jimenez-Lara AM, Tolon RM, Aranda A. Mol Endocrinol; 1999 Jul 07; 13(7):1141-54. PubMed ID: 10406465 [Abstract] [Full Text] [Related]
16. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene. Nanes MS, Kuno H, Demay MB, Kurian M, Hendy GN, DeLuca HF, Titus L, Rubin J. Endocrinology; 1994 Mar 07; 134(3):1113-20. PubMed ID: 8119149 [Abstract] [Full Text] [Related]
17. 1alpha,25-dihydroxy vitamin D3-enhanced expression of the osteocalcin gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1alpha,25-dihydroxy vitamin D3 receptor-SRC-1 coactivator complex. Carvallo L, Henríquez B, Paredes R, Olate J, Onate S, van Wijnen AJ, Lian JB, Stein GS, Stein JL, Montecino M. J Cell Physiol; 2008 Mar 07; 214(3):740-9. PubMed ID: 17786964 [Abstract] [Full Text] [Related]
18. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor. Thompson PD, Hsieh JC, Whitfield GK, Haussler CA, Jurutka PW, Galligan MA, Tillman JB, Spindler SR, Haussler MR. J Cell Biochem; 1999 Dec 01; 75(3):462-80. PubMed ID: 10536369 [Abstract] [Full Text] [Related]
20. Basal and vitamin D-responsive activity of the rat osteocalcin promoter in stably transfected osteosarcoma cells: requirement of upstream sequences for control by the proximal regulatory domain. Frenkel B, Montecino M, Green J, Aslam F, Desai R, Banerjee C, Stein JL, Lian JB, Stein GS. Endocrinology; 1996 Mar 01; 137(3):1080-88. PubMed ID: 8603577 [Abstract] [Full Text] [Related] Page: [Next] [New Search]